Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 7-Day Trial for You or Your Team.

Learn More →

Serologic subsets in systemic lupus erythematosus

Serologic subsets in systemic lupus erythematosus A search for anti‐Ro or anti‐nRNP antibodies by precipitin analysis among a population of 64 patients with systemic lupus erythematosus (SLE) or mixed connective tissue disease was undertaken. The 25% of SLE patients with anti‐Ro did not have any distinct clinical features, compared to patients without anti‐Ro or to anti‐nRNP patients with SLE or mixed connective tissue disease. However, these patients did have a significantly greater frequency of rheumatoid factor (80%). Most importantly however, patients with anti‐Ro had a significantly increased frequency of HLA‐B8 (81%) and HLA‐DRw3 (100%) compared to patients with anti‐nRNP (B8—29%; DRw3—33%) or SLE patients without such antibodies (B8—41%; DRw3—25%). These data suggest the existence of a specific immune response gene for Ro close to the D region of the major histocompatibility complex. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Arthritis & Rheumatism Wiley

Serologic subsets in systemic lupus erythematosus

Arthritis & Rheumatism , Volume 23 (11) – Nov 1, 1980

Loading next page...
 
/lp/wiley/serologic-subsets-in-systemic-lupus-erythematosus-CvmUTniEZD

References (38)

Publisher
Wiley
Copyright
Copyright © 1980 American College of Rheumatology
ISSN
0004-3591
eISSN
1529-0131
DOI
10.1002/art.1780231107
Publisher site
See Article on Publisher Site

Abstract

A search for anti‐Ro or anti‐nRNP antibodies by precipitin analysis among a population of 64 patients with systemic lupus erythematosus (SLE) or mixed connective tissue disease was undertaken. The 25% of SLE patients with anti‐Ro did not have any distinct clinical features, compared to patients without anti‐Ro or to anti‐nRNP patients with SLE or mixed connective tissue disease. However, these patients did have a significantly greater frequency of rheumatoid factor (80%). Most importantly however, patients with anti‐Ro had a significantly increased frequency of HLA‐B8 (81%) and HLA‐DRw3 (100%) compared to patients with anti‐nRNP (B8—29%; DRw3—33%) or SLE patients without such antibodies (B8—41%; DRw3—25%). These data suggest the existence of a specific immune response gene for Ro close to the D region of the major histocompatibility complex.

Journal

Arthritis & RheumatismWiley

Published: Nov 1, 1980

There are no references for this article.